Fitting homocysteine to disease models, as well as adjusting the models to the disease

Journal of Molecular Medicine

Volumn 93, Issue 6, 2015, Pages 585-587

  Luft, Friedrich C ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ANIMAL; CARDIOVASCULAR DISEASES; DISEASE MODEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; METABOLISM; OXIDATIVE STRESS; RISK FACTOR; SIGNAL TRANSDUCTION;

ANIMALS; CARDIOVASCULAR DISEASES; DISEASE MODELS, ANIMAL; FOLIC ACID; HOMOCYSTEINE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); OXIDATIVE STRESS; RISK FACTORS; SIGNAL TRANSDUCTION; VITAMIN B 12;

EID: 84937763283     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-015-1293-z     Document Type: Editorial

References (12)

1. Dayal S, Lentz SR (2008) Murine models of hyperhomocysteinemia and their vascular phenotypes. Arterioscler Thromb Vasc Biol 28(9):1596–1605
2. Fodinger M, Horl WH, Sunder-Plassmann G (2000) Molecular biology of 5,10-methylenetetrahydrofolate reductase. J Nephrol 13(1):20–33
3. Marti-Carvajal AJ, Sola I, Lathyris D, Karakitsiou DE, Simancas-Racines D (2013) Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev 1:CD006612
4. Marti-Carvajal AJ, Sola I, Lathyris D (2015) Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev 1:CD006612
5. Marti-Carvajal AJ, Sola I, Lathyris D, Salanti G (2009) Homocysteine lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev 4:CD006612
6. Mei W, Rong Y, Jinming L, Yongjun L, Hui Z (2010) Effect of homocysteine interventions on the risk of cardiocerebrovascular events: a meta-analysis of randomised controlled trials. Int J Clin Pract 64(2):208–215
7. Blencowe H, Cousens S, Modell B, Lawn J (2010) Folic acid to reduce neonatal mortality from neural tube disorders. Int J Epidemiol 39(Suppl 1):i110–i121
8. Muthuramu I, Singh N, Amin R, Nefyodova E, Debasse M, Horenbeeck IV, Jacobs F, De Geest B (2015) Selective homocyseine-lowering gene transfer attenuates pressure-overload-induced cardiomyopathy via reduced oxidative stress. J Mol Med. doi:10.1007/s00109-015-1281-3
9. Real JT, Martinez-Hervas S, Garcia-Garcia AB, Chaves FJ, Civera M, Ascaso JF, Carmena R (2009) Association of C677T polymorphism in MTHFR gene, high homocysteine and low HDL cholesterol plasma values in heterozygous familial hypercholesterolemia. J Atheroscler Thromb 16(6):815–820
10. Kuehl K, Loffredo C, Lammer EJ, Iovannisci DM, Shaw GM (2010) Association of congenital cardiovascular malformations with 33 single nucleotide polymorphisms of selected cardiovascular disease-related genes. Birth Defects Res A Clin Mol Teratol 88(2):101–110
11. Hoffman M (2011) Hypothesis: hyperhomocysteinemia is an indicator of oxidant stress. Med Hypotheses 77(6):1088–1093
12. Leopold JA (2015) Antioxidants and coronary artery disease: from pathophysiology to preventive therapy. Coron Artery Dis 26(2):176–183